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The composition and in vitro expression of the cag pathogenicity island genes in a group of fielkobacter pylori 
strains obtained from patients suffering from chronic gastritis-associated dyspepsia (n = 26) or gastric 
carcinoma (it = 17) were analyzed. No significant difference in the distribution of the 10 studied regions was 
found between the cases and the controls. Nine strains did not harbor any of the selected regions: eight (30.8%) 
isolated from patients with gastritis only and one (5.9%) from a patient with gastric carcinoma. No association 
was found between the number of repeated sequences at the 3' end of the cagA gene or the presence of tyrosine 
phosphorylation motifs and the clinical origin of the strains. The virBIO homolog gene was the sole gene 
studied to be significantly expressed more often in cancer strains than in gastritis strains (P = 0.03). 
Since the first culture of Helicobacter pylori in 1982, chronic 
infection with this bacterium has been identified as the etio-
logical agent of gastritis and duodenal ulcer (18, 21). Evidence 
for a causal relationship between chronic H. pylori infection 
and stomach cancer came first from epidemiological studies 
(10, 19) and, more lecently, from animal models of carcino-
genesis (12, 32). In 1994, the International Agency for Re-
search on Cancer-World Health Organization (11) defined H. 
pylori infection as a group I carcinogen (definite carcinogen). 
Despite the very high rate of H. pylori infection in some 
populations, the rate of gastric cancer is relatively low. Beside 
environmental factors and hereditary predisposition, as' re-
cently illustrated with interleukin-1 13 polymorphism (8), a pos-
sible explanation may be found in the different patterns of 
pathogenicity of H. pylori strains. The cog pathogenicity island 
(PAI) is one of the major H. pylori virulence factors found 
more frequently in patients suffering from severe gastroduo-
denal diseases, including peptic ulcers (5, 13, 16) and gastric 
adenocarcinomas (16, 26). 
Recent studies have shown that the CagA protein, encoded 
by the cag PAI, is translocated into host cell by the cag PAI 
type IV secretion system, by which it becomes phosphorylated 
by an unknown cell kinase (4, 25, 27, 31), inducing an active 
reorganization of actin (31). The sites of possible phosphory-
lation of CagA have been identified (25). The CagA protein 
varies in size from 128 to ca. 140 kDa, and this variation is 
related to the presence of a variable number of repeated se-
quences in the 3' region of the gene (9, 35, 36). 
The aim of this study was to compare the presence, the 
composition, and the expression of several cag PAI genes, 
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including cagA, in Costa Rican strains obtained from patients 
suffering from gastric carcinoma (n = 17) and from chronic .  
gastritis-associated dyspepsia (ii = 26), as well as to determine 
the terminal sequence of the cagA gene and the putative ty• 
rosine phosphorylation motifs (IPMs) of the deduced CagA 
protein. 
Molecular composition of the cag PAI among I? pylori 
strains. After culture of the 43 H. pylon isolates on selective 
medium (20), the DNA was extracted using the standard phe-
nol-chloroform procedure (24). Four reference strains were 
included in the study: J99 (3), 26695 (33), NCTC 11638 (2, 5), 
and SS1 (15). The presence of cag PAI was analyzed by de-
tecting 10 different regions (the 5' and 3' ends of cagA, cagC, 
virB4/cagF, cagLIcagNIcagM, cagPlcagQIcagR, cagSlvirBZ virB9, 
virB10, virB11, and virD4) by PCR amplification and dot blot 
hybridization as previously described (24). The presence of 
1S605 (tnpA and tnpB) was also evaluated (Table 1). An ex-
ample of cagLIcaglifIcagN and IS605 detection by PCR is pre-
sented in Fig. IA. As expected, a 1,803-bp fragment was re-
vealed for the strains NCTC 11638, J99, and 26695, and no 
amplification was obtained in the control when DNA was re-
placed by water (lane NC). Among the 22 clinical strains pre-
sented in this figure, 15 yielded the expected fragment. In the 
case of IS605 amplification, a 1,486-hp amplicon was obtained 
in positive controls (26695 and NCTC 11638 strains), as well as 
in six strains among the 22 presented. As expected from the 
genome sequence, the IS605 fragment was not amplified from 
DNA of strain J99. 
Negative results by PCR may be due either to an absence of 
the tested gene (true negative) or to a lack of primer annealing 
due to interstrain variation in the sequences targeted by the 
primers. For this reason, dot blot analyses were performed to 
confirm the absence of the selected genes by hybridization 
conducted under stringent conditions and as described else-
where (24). Moreover, the specificity of the amplicons was also 
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TABLE 1. Primer sequences and DNA amplification conditions for each selected region 
Primer sequence (5'-)3') 
Size of 
amplified 
fragment (bp) 
Annealing step 
0]. 
time E
=PN
MMY' 
ATA ATO CTA MT TAO ACA ACT TGA OCO A 298 51; 1.5 
TTA GAA TAA TCA ACA AAC ATC ACO CCA T 
GAT AAC AGO CAA COT TTT CAG OGA 394 60,:1 
CCG AAC GOA TCA AM ATT CAT GO 
ACC CTA OTC GOT AAT GOO TTA 545 62, 1.5 
GGC TOT TAG TAG COT MT TOT C 
GCG TM OCA MA ACA OTC GCC TGA 412 51, 1.5 
AAG AAA MT OGT TOG GAC MG TAG 
See above 241 52,1 
CM GM TCA CTOfixtcA OCT ACA AG , 
CAC TCT CM TGA 	 COT TAT GM c 2,675 500 1.5 
CTT TOT CAA OTC ATT TCT CAG 
See above 	 594 	 60, 1 
CTG CCT AOC OTA ATA TCA CC 
See above 	 261 	 60, 1 
CCT CGC TTA TOT TOT TAT TO 
TAT TGT CM TTT TGA TOO CAO AAG 
	
1,803 	 48, 13 
TGA TGA GCG ACA AAA CAA CTA TOC 
See above 	 354 	 60, 1 
COO ATA TTC CGC ATT OTT GC 
CGC CAC TM CGC TTT GAG 	 277 	 60,' 1 
COG AGC AOC AGO TTT CAC 
GCA TOG 03A TM ATA AGA TC 
	
254 	 60, 1 
CAT AGO ATC OCT ATC TAC 0 
TAT TGC CTC OTT GAT CAA ACA AAG CTC TGC 	 1,327 	 47, 13 
GAT TTG GAO TTA GAT TAG GOT GOT 
AOC CTT TAT TAT AGO CTG TTC 	 260 	 58, 1 
MC CAA TTT TOC CAT TGA GTC 
TGC TTC CTA CTA MA CAC GC 
	
309 	 58, 1 
CAA CCA MG CAO ATC CCA TO 
AAG TOC ATO CAG TM TTA TOC GAA 	 1,627 	 47, 13 
TCT AM GAG AAA CCA MT CCA TTG 
aao AGC OTT AGA TM GOT TC 
	
279 	 58, 1 
GTG GOA GCT TAG TGC CAT AC 
CTG ATA GAO MO TAT kW GAG 	 337 	 58, 1 
OCA ACA CAT CAA AGG TCT 
GTT GOC TGT TTC TOT CTT GO 
	
339 	 60, 1 
GTA ATC TCT TOT CAT TAG GGC 
GAT GM ATC CAA A AGO CAA O 	 376 	 60, 1 
CCA CTT GAA CTT 
	 OTT GO 
TAC CTA GCA MA CM CCT ATC CTC 
	
1,955 	 48, 13 
TCC ACA TOT TTC TAG TAG CAG GAC 
ATO ACT GAA GAC AGA TM AG 	 506 
	 58, 1 
GCA ATA CCA TCT TTA ATC GC 
CTT TOG CTT TTG OTT OCA AG 
	
513 	 58, 1 
CTA OTA OCik GCA ATC MG C 
TCA TCO CTC CAT MC TAG C 	 1,486 	 54, 1.5 
OGT GGC TAT CTC ATC TAT MC AGA 
GCT TOC TTO TAT TOG CCT TO 
	
324 	 58,, 1 
GCA TGC ACA TTC CCT MA GTO 
GTO CTT ATT COT TAO ATA COG TCA T CTA OCA AOC 
	 399 	 55,1 
TAG MG CTT CAT COT 1' 
• v, Primers used for PCR amplification (direct analysis dm PA1 in clinical strains by PCR and probe obtendon for dot blot hybridization). The sequence of these 
primers was derived from the published sequence of eag PA1 region of H. pylori NCTC 11638 (GenBank accession numbers U60176, U60177, and AC000106) (2, 5). 
t, Primers used for RT-PCR analysis of eag PAl genes; their sequences were derived from the published sequence of the H. pylori strains NCTC 11638 (GenBank 
accession numbers U60176, U60177, and AC000108) (2, 5), 199 (http://scriabin.astrazeneca-boston.comAmylori), and 26695 (http://www.fignorg). t Primers used for 
PCR amplification and sequencing. 
h Annealing step for each cycle. The cycling programs were proceeded by one step at 94'C for 5 min; 35 cycles were applied; each consisted of 1 min at WC, annealing 
ac specified in the table, and Trc for a time dependent on the expected product size (1 min'per kb). Finally, an elongation step at 7?C for 7 min was added. 
confirmed by this technique. Dot blot analysis were then per-
formed on all strains with all of the probes. An example of 
detection of the cagLIcagMlcagN region and 15605 by hybrid-
ization is illustrated in Fig. 1B with the same strains as used for 
PCR detection (Fig. 1A). The same results were obtained for  
all of these strains except for strain SS1, which gave positive 
results by dot blot and negative results by PCR. With the IS605 
probe, two contradictory results were obtained with DNA from 
strains in the lines 5 and 14. In summary, the correlation 
between the results obtained by PCR and those obtained by 
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FIG. I. Detection of the cagLIcar,NIcagM region and IS605 by PCR (A) and dot blot hybridization (B) for 22 clinical H. pylori strains and for 
the 4 reference strains. A schematic representation of DNA isolate positions is in the center. The sizes of amplified fragments are indicated in base 
pairs. NC, negative control. 
dot blot were 100% for cagC, virB4IcagF, cagS/virBZ vh
-B9, 
virB10, virB1I, and virD4; 97.9% for cagA D008-R008, cagA 
Y s- A6, and cagL/cagM/cagN; and 95.7% for cagP/cagR and 
IS605. A strain was defined as lacking a given region if the 
results obtained both by PCR and by hybridization were neg-
ative. In the case of a given region detected by hybridization 
and not by PCR, the strain was considered positive for this 
region. The reverse case (positive PCR and negative hybrid-
ization) was never observed. 
According to the rule established above, the results were 
analyzed first globally and then according to the associated 
disease. Comparison of open reading frame (ORF) patterns 
obtained from the different strains was performed using the 
unweighted-pair-group method with averages (30). The distri-
bution of the selected cag PAI regions among strains is pre-
sented in Fig. 2. Each strain was assigned to a pattern based on 
the presence or absence of the selected region. The strains 
could be classified into four groups. The largest group included 
% tr•26 % n-17 % n=43 
32 74.4 II 69.2 14 12.3 
I 2.3 0 0 1 19 
1 2.3 0 0 1 5.9 
9 21 30.3 1 3.9 
+ 
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FIG. 2. Distribution of the cog PAI selected regions in the 43 H. pylini strains isolated from patients with chronic gastritis-associated dyspepsia 
(g) or gastric carcinoma (C). The four different patterns are presented in the left of the figure. The status for each selected region is presented 
(each pattern showed positive (+] or negative [—] hybridization with each probe). The different probes, as well as the two flanking genes, HP519 
and HP549, are indicated at the top. The boundaries of the cag PAI are indicated by black boxes. The numbers and the percentages of clinical H. 
pylori strains presenting the different patterns are indicated at the right of the figure. 
32 strains (74.4%) which were positive for all of the cag PAI 
regions studied. One strain (2.3%) exhibited a deletion of the 
cagA gene while the other regions were present, and one cagA-
positive strain (2.3%) lacked all other regions, indicating that 
an association between cagA and cag PAI, while very strong, is 
not absolute. The fourth group included nine strains (21%) 
which contained none of the cag PAI regions studied. The SS1 
reference strain was found to be positive for all of the regions 
studied (type I strain). 
In order to confirm the complete absence of cag PAI in the 
nine strains, an amplikation was performed using two primers 
(Table 1) located in the two genes flanking the cag PAI in the 
reference strains (HP519 and HP549; Fig. 2). As expected 
from the literature (1, 14), a single 324-bp amplicon was ob-
tained from each of the nine cog PM-negative strains. The 
nudeotide sequences of the so-called "empty site" were deter-
mined and deposited in GenBank under the accession num-
bers AF289390 to AF289398. The nine strains considered to be 
cag PM negative based on PCR and dot blot results were, 
therefore, confirmed to be truely cag PAI negative. 
The results are also presented according to the associated 
disease (Fig. 2). The proportion of each expression profile was 
compared between strains isolated from patients with gastric 
carcinoma and patients with chronic gastritis-associated dys-
pepsia using the chi-square test. Strains with no cag PAI re-
gions were found more frequently among gastritis strains than 
among carcinoma strains, but the difference was not statisti-
cally significant (30.8 versus 5.9%, respectively, P = 0.11). At 
the same time, strains containing all of the tested cag PAI 
regions were found more frequently among the gastric carci-
noma strains (823%) than among the gastritis strains (69.2%). 
However, this difference was still not significant (P = 0.28). 
Profiles II and III were not considered in this analysis because 
they did not contain enough strains (n = 1 in each group). 
Concerning the results obtained for IS661, 11 strains were 
found to be positive (25.6%): 8 in the gastritis group (30.8%) 
and 3 in the carcinoma group (17.6%). Although 15605 seemed 
to be more frequently found in strains isolated from patients 
with gastritis than in those isolated from patients with gastric 
cancer, this difference was not significant (P = 0.54). 
Analysis of the cagA terminal sequences. The sequence of 
two fragments of the cagA gene (at the 5' and 3' ends) was 
analyzed for the 33 cagA-positive strains. The 5' end amplioons 
were identical in size (394 bp), and their nudeotide sequences 
exhibited an overall similarity of 96.8% (accession numbers 
AF289399 to AF289413 for the gastric carcinoma strains and 
accession numbers AF289432 to AF289431 for the gastritis 
strains). In contrast, an interstrain size variation of the Ys-A6 
fragment of the cagA gene (3' end) was observed (from 570 to 
680 bp). Each amplicon was therefore submitted to sequencing 
(accession numbers AF289432 to AF289446 for the carcinoma 
strains and accession numbers AF289447 to AF289464 for the 
gastritis strains). The deduced amino acid sequences obtained 
were analyzed according to the method of Evans et al. (9). 
Eleven different sequence types were obtained, indicating a 
large variability. Regarding the number of repeated sequences, 
23 strains contained only one repeat (69.7%) and 10 strains 
contained two repeats (303%). No example of three repeats 
was found. The number of repeats was analyzed according to 
the origin of the strains. Although two repeated sequences 
were found more frequently in strains from patients with gas-
tric cancer (40 versus 22.2%), this difference was not significant 
(P = 0.46). 
Analysis of TPMs of the CagA protein. To determine 
whether the CagA protein of the clinical strains was phosphor-
ylated, putative CagA TPMs were sought in their sequences. 
Three sites of phosphorylation have been recently identified by 
Odenbreit et al. (25): site "A" (KFGDQRY) at amino acid 
(aa) 122, site "B" (KNSTEPY) at as 899, and site "C" (KUM 
STKY) at aa 1029. Thus, the sequences of the two fragments of 
the cagA gene which may contain these three sites (TPM A in 
the A1-A2 fragment and TPMs B and C in the Ys-A6 frag-
ment) were analyzed. The cagA sequences of all 33 Costa 
Rican strains have the TPM KFGDQRY in position A Nine-
teen strains (12 of 15 patients with gastritis and 7 of 18 patients 
with gastric carcinoma) presented the TPM KNST/GEPY in 
position B, the other strains having a variable sequence which 
did not correspond to a phosphorylation motif (KNEPIY, 12 
strains; ENSAEPY, two strains). No strain had a TPM in 
position C. Thus, globally, the majority of the strains (57.6%) 
No. of 
tenes 43)  Total (pi =  
Gastric 
cardaoma 
patient isolates 
No. 	 % No. 
(n = 26) 	 (a = 17) 
Gastritis 
patient 
isolates 
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was similar to the 26695 strain which contains TPMs A and B. 
The remaining strains contained only the TPM A site, as did 
the strain NCTC 11638. In conclusion, the CagA protein from 
all of the Costa Rican strains tested contained at least one 
TPM; however, no association was found between the number 
of TPMs and the type of disease from which the strain origi-
nated. Indeed, 66.7% of the strains from patients with chronic 
gastritis only presented two TPMs (A and B) in the CagA 
protein versus 46.7% of the gastric carcinoma strains (P 
0.24). 
Expression of the cag PAI genes in H. pylori strains. To 
investigate whether the ORFs present in the cag PAI regions 
were expressed in vitro, transcription of 15 genes of cak.PAI 
(capt, cagC, virB4, cagF, cagL, cagN, cagM cagP, cagQ, cagS, 
virB7, virB9, virB10, virB11, and virD4) was investigated by 
reverse transcription using a random primer mixture followed 
by a PCR (Enhanced Avian RT-PCR Kit; Sigma Aldrich, St. 
Quentin Fallavier, France) with specific primers (Table 1). 
RNA from an in vitro H pylori culture was isolated according 
to the previously described method (24). Among the 15 genes, 
only one was found to be expressed in all of the strains under 
the conditions tested (cagF). The expression of five genes 
(cagC, cagP, cagQ, virB11, and virD4) was never detected. The 
other genes (n = 9) were differentially transcribed among the 
cag PAI-positive strains: cagL in only 1 strain (3%), cagS and 
virB4 in 4 strains (12.1%), cagN and virB9 in 5 strains (15.1%), 
virB7 in 7 strains (21.2%), cagM in 11 strains (33.3%), virB10 in 
21 strains (63.6%), and cagA in 29 strains (87.9%). No corre-
lation could be drawn from this analysis. However, two pairs of 
genes seemed to he linked: cagP and cagQ on the one hand and 
virB11 and virD4 on 	 other hand. Indeed, when the cagP 
gene was not expressed, cagQ was not expressed either. The 
same observation was noted for the virB11 and virD4 genes. 
This fact, together with their relative locations (Fig. 2), sug-
gested that these pairs of genes belong to the same transcrip-
tional unit and may be coregulated. The expression states of 
genes was analyzed according to the disease of the patiEnts 
from whom the strains were isolated (Table 2). The only cag 
PAI gene for which a statistically significant difference was 
found (P = 0.03) was the virB10 gene, whose transcript was 
detected in 21 strains (48.8%), among which 9 were isolated 
from gastritis patients (34.6%) and 12 were isolated from car-
cinoma patients (70.6%). A trend, while not statistically signif-
icant, was also observed for cagN (P = 0.07) and cagM (P 
0.08) expression. 
The first question posed in this study was whether the de-
velopment of gastric carcinoma in Costa Rica, known to dis-
play a high incidence of this pathology (29), is associated with 
the presence of cag PAI in infecting H. pylori strains. The 
results of our study showed that, in this country, most of the H. 
pylori strains are positive for the cag PAI (74.4%). Neverthe-
less, while no statistically significant difference was found, eight 
of the nine strains with no cag PAI were isolated from patients 
with gastritis but only one was isolated from a gastric carci-
noma patient, indicating a tendency (P = 0.11). There are 
controversial reports concerning the association of the cag 
PAI-positive H. pylori and more severe gastric diseases such as 
peptic ulcer disease and gastric carcinoma. Most of the reports 
from Western countries (Europe and the United States) (5, 13) 
found a positive association, while no association was found in 
INFscr. IMMUN. 
TABLE 2. Distribution of mqwessed genes of the cog PAI between 
gastritis and gastric carcinoma strains 
cagA• 29 67.4 16 61.5 13 76.5 03 
ccigCt 0 0 0 0 0 0 
virB4* 4 9.3 3 11.5 1 5.9 0.6 
ca&F. 34 79.1 18 69.2 15 94.1 0.1 
cagLa 1 2.3 0 0 1 5.9 0.4 
cagN* 5 11.6 1 3.8 4 23.5 0.07 
cagM 11 25.6 4 36.4 7 63.6 0.08 
cagPt 0 0 0 0 0 0 
cagQt 0 0 0 • 0 0 0 
mg* 4 93 4 15.4 0 0 0.1 
virB7* 7 16.3 4 15.4 3 17.6 1 
0199* 5 11.6 5 19.2 0 0 0.1 
vir8.10* 21 48.8 9 34.6 12 70.6 0.03 
virB1 lt 0 0 0 0 0 0 
virD4t 0 0 0 0 0 0 
Genes expressed in the 199 and 26695 strains; t, genes not expressed in the 
399 and 26695 strains; g, gene expressed in the J99 strain but not in the 26695 
strain. 
b Data obtained by using Fisher's exact test. 
the Far East (23). This fact can be explain by the high back-
ground level of cag PAI-positive H. pylori strains in far eastern 
countries which prohibits making conclusions based on cross-
sectional or case-control studies. It is also possible that, while 
all H. pylori strains lead to cancer if the patient lives long 
enough, the process may develop more quickly in certain in-
dividuals due to environmental and individual genetic factors. 
However, concerning the absence of the cag PAI in strains 
isolated from patients with more severe disease (one case in 
the present study), it cannot be excluded that the strains stud-
ied, which were present at the time of carcinoma diagnosis, 
were not necessarily the carcinogenic strains, since gastric car-
cinoma evolves over several decades. Indeed, the possibility of 
harboring several strains successively, especially in a country 
with a high prevalence of infection, does exist (22, 23, 28). 
Despite the fact that cag PAI is present in most of the strains, 
it may be that the composition of the cag PAI genes or the 
regulation of their expression varies and influences the associ-
ated pathogenicity. 
Therefore, in the present study, the composition of the cag 
PAI was analyzed in depth. The regions sought were chosen 
based on their location on the island as well as on the putative 
role of the ORFs encoded (2, 4, 5, 25, 27, 31, 34). Our results 
did not show an association between a particular region and 
the disease status: in 32 H. pylori clinical strains, 10 different 
regions of the cag PAI corresponding to 16 ORFs were all 
present, and therefore the strains could be categorized as type 
I according to Censini et al. (5). Interestingly, in one strain, the 
cagA gene itself was absent, whereas the other regions of the 
cag PAI were present, indicating that the use of this gene as the 
sole marker for the detection of the cag PAI may sometimes 
lead to erroneous results. Furthermore, in another strain, iso-
lated from a gastric carcinoma patient, the cagA gene was the 
only part of the cag PAI present, leading us to the question of 
what are the pathogenic properties of this strain because the 
VOL 69, 2001 
type IV secretion system which delivers the CagA protein into 
the epithelial cells is encoded by genes which are absent. 
The variation of the CagA protein size has been related to 
the presence of a variable number of repeated sequences in the 
3' end of the gene (9). The presence of these multiple repeats 
in the COOH terminus of the protein was found to be associ-
ated with the development of gastric carcinoma in Japanese 
(36), U.S., and Colombian H. pylori strains, but not in Korean 
strains (35). In our study on Costa Rican strains, it was not 
possible to confirm this association. 
In a recent study, Odenbreit et al. (25) studied the tyrosine 
phosphorylation of the CagA protein in several H. pylori ref-
erence strains and established that the translocation C4' the 
CagA protein, as well as the presence of at least one of three 
TPMs in the CagA protein, is necessary for CagA phosphory-
lation; therefore, this characteristic may be relevant in terms of 
disease association. Thus, such motifs were sought in the de-
duced CagA protein sequence in the strains included in our 
study. The results show that half of them contained only one 
phosphorylation site (at position 122), such as strain NOV 
11638. whose CagA protein is weakly phosphorylated (25). The 
remaining strains presented two phosphorylation sites (at po-
sitions 122 and 899), such as strain 26695, which exhibited a 
moderate phosphorylation of the CagA protein. This dichot-
omy was independent of the clinical origin of the strain. It is 
possible that the CagA protein of all the Costa Rican strains is 
phosphorylated. These data could be confirmed by detection of 
phosphorylated tyrosine and translocated CagA proteins in 
epithelial cell cultures infected by these strains. 
For the first time, we reported the in vitro expression of 14 
cag PAI genes in attention to the cagA gene for all the clinical 
strains. Our results showed that the cagA gene is expressed in 
vitro in 87.9% of the strains. In a previous study, Maeda et al. 
(16) reported also the differential expression of the cagA gene 
in various H. pylori strains. Among the ORFs which were never 
expressed, two gene pairs, cagP-cagQ and virB11-virD4, were 
located in close proximity and were similarly orientated, null-
eating their possible inclusion in two independent operons. 
The genes whose encoded proteins form the secretion system 
IV were expressed differentially among the strains. The virBIO 
gene was expressed more frequently in carcinoma than in gas-
tritis-only strains (P = 0.03). However, two of these genes were 
never expressed (virB11 and virD4). It is possible that these 
genes, which are involved in the translocation of the CagA 
protein into gastric cells, are only expressed following the con-
tact of the bacterium with the epithelial cell, and therefore 
their expression could not be detected in vitro. 
The 1S605 element was found in 11 of 43 isolates (26.5%). 
This proportion is similar to that found by Kersulyte et al. (14) 
using hybridization or PCR on a set of strains originating from 
patients also living in Latin America, including Peru (13 of 69, 
19%) and Guatemala (16 of 44, 36%). 
Despite an in-depth exploration of the composition of the 
cag PAI and the known characteristics of what is now consid-
ered to be a major pathogenicity factor, i.e., the cagA gene, we 
were able to find only one element (the expression of the 
virR10 homolog gene) which was associated with the severe 
outcome of H. pylori infection, i.e., gastric carcinoma. It seems 
that the cag PAI constitutes a group of genes encoding proteins 
which are highly complementary in their function since they  
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have been transmitted as a whole throughout evolutionary 
events subsequent to their incorporation. 
Comparison of the genome of strains J99 and 26695 (3, 7,17, 
33) showed the presence of other regions whose role in patho-
genicity remains to be explored. It is likely that virulence re- 
sults from a combination of various factors, such as the pres-
ence of the cag PAI together with that of such regions as those 
encoding, cytotoxin production, and adhesin expression, rather 
than the presence of a unique virulence factor (6). Moreover, 
a study of the transcriptome under more physiological condi-
tions and of the proteome may, in the future, provide infor-
mation on additional elements for what remains the most im-
portant pathogenic determinant of H. pylori. 
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